Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tissue-Drug Binding: Localization of Drugs and its Significance01:24

Tissue-Drug Binding: Localization of Drugs and its Significance

Body tissues, comprising approximately 40% of the body weight, are crucial in drug distribution and localization. These tissues can serve as drug storage sites, competing with plasma binding sites for drug molecules.
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Thyroid Function Parameters, Thyroid Status, and Vitamin B12 Deficiency in Hospitalized Adults: A Retrospective Cross-Sectional Study in Eastern India.

Cureus·2026
Same author

Coexistence of Anaemia and Common Morbidities Among Children in India Below the Age of Five Years: Evidence From the National Family Health Survey-5 (2019-21).

Cureus·2026
Same author

Pathogen-mediated priming induces intergenerational immunity against spot blotch in wheat.

World journal of microbiology & biotechnology·2026
Same author

Anti-CRISPR-mediated continuous directed evolution of CRISPR-Cas9 in human cells.

Proceedings of the National Academy of Sciences of the United States of America·2026
Same author

Machine learning framework for cost effective deep mutational scanning through targeted substitution profiling.

BMC bioinformatics·2026
Same author

Gold nanoparticle-based electrophoresis-free colorimetric detection method for allele-specific PCR-SNP genotyping.

Analytical biochemistry·2026
Same journal

Regulation of amygdala and dopamine system in naïve and chronic alcohol states.

Alcohol (Fayetteville, N.Y.)·2026
Same journal

The Effects of Developmental Ethanol Exposure & Postnatal Choline Supplementation on Long-Term Choline Metabolism.

Alcohol (Fayetteville, N.Y.)·2026
Same journal

Early ethanol exposure during gestation and lactation disrupts gut integrity and enhances ethanol intake in C57BL/6 mice offspring.

Alcohol (Fayetteville, N.Y.)·2026
Same journal

Effects of acute alcohol on pain-related activity of the anterior and posterior insular cortices.

Alcohol (Fayetteville, N.Y.)·2026
Same journal

Adolescent ethanol exposure produces sex-dependent modulation of ethanol-induced analgesia and cell type-specific vlPAG activation.

Alcohol (Fayetteville, N.Y.)·2026
Same journal

Impact of impaired endogenous neurosteroidogenesis on outcomes following chronic alcohol exposure.

Alcohol (Fayetteville, N.Y.)·2026
See all related articles

Related Experiment Video

Updated: Jun 17, 2026

Modification and Functionalization of the Guanidine Group by Tailor-made Precursors
09:45

Modification and Functionalization of the Guanidine Group by Tailor-made Precursors

Published on: April 27, 2017

A physiologically based model for ethanol and acetaldehyde metabolism in human beings.

David M Umulis1, Nihat M Gürmen, Prashant Singh

  • 1University of Michigan, Department of Chemical Engineering, Ann Arbor, 48109-2136, USA.

Alcohol (Fayetteville, N.Y.)
|June 1, 2005
PubMed
Summary
This summary is machine-generated.

This study introduces a new physiologically based pharmacokinetic model to accurately predict ethanol and acetaldehyde levels in the body. The model accounts for acetaldehyde

More Related Videos

Preparation and Evaluation of 99mTc-labeled Tridentate Chelates for Pre-targeting Using Bioorthogonal Chemistry
10:54

Preparation and Evaluation of 99mTc-labeled Tridentate Chelates for Pre-targeting Using Bioorthogonal Chemistry

Published on: February 4, 2017

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
07:16

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

Published on: August 16, 2018

Related Experiment Videos

Last Updated: Jun 17, 2026

Modification and Functionalization of the Guanidine Group by Tailor-made Precursors
09:45

Modification and Functionalization of the Guanidine Group by Tailor-made Precursors

Published on: April 27, 2017

Preparation and Evaluation of 99mTc-labeled Tridentate Chelates for Pre-targeting Using Bioorthogonal Chemistry
10:54

Preparation and Evaluation of 99mTc-labeled Tridentate Chelates for Pre-targeting Using Bioorthogonal Chemistry

Published on: February 4, 2017

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
07:16

Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission

Published on: August 16, 2018

Area of Science:

  • Pharmacology
  • Biomedical Engineering
  • Toxicology

Background:

  • Existing pharmacokinetic models for ethanol metabolism do not account for toxic acetaldehyde accumulation.
  • Acetaldehyde accumulation causes adverse effects like cardiac arrhythmias, nausea, and facial flushing.
  • Measuring acetaldehyde levels is challenging due to artifactual formation and technical issues.

Purpose of the Study:

  • To develop a physiologically based pharmacokinetic (PBPK) model for ethanol and acetaldehyde.
  • To accurately simulate ethanol and acetaldehyde concentration-time data.
  • To investigate the role of the reverse reaction of acetaldehyde metabolism.

Main Methods:

  • Constructed a five-compartment PBPK model (stomach, GI tract, liver, central fluid, muscle).
  • Modeled liver as a tubular flow reactor and other compartments as stirred reactors.
  • Derived enzymatic rate laws for alcohol dehydrogenase (ADH) and acetaldehyde dehydrogenase (ALDH).
  • Determined kinetic parameters from literature and optimized by minimizing squared error.

Main Results:

  • The PBPK model accurately matched existing ethanol and acetaldehyde concentration-time data.
  • Model output strongly correlated with experimental results in healthy individuals.
  • Model accurately predicted outcomes in individuals with ALDH2 genetic deficiency.
  • The reverse reaction of acetaldehyde to ethanol was found to be essential.

Conclusions:

  • The developed PBPK model provides a robust tool for studying ethanol and acetaldehyde pharmacokinetics.
  • The model highlights the critical role of the reverse acetaldehyde reaction in maintaining lower concentrations.
  • This approach improves understanding of ethanol toxicity and individual variability in metabolism.